Osilodrostat Uses, Dosage, Side Effects and Interactions
Isturisa
Isturisa was the first osilodrostat product the FDA approved, in March 2020. No generic is listed as tablets.
Osilodrostat (Isturisa) is a cortisol-lowering pill for adults with Cushing's syndrome when surgery isn't an option or hasn't cured it.
Quick links
Ask Anything About OsilodrostatType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Osilodrostat in Short
- Drug class Cortisol Synthesis Inhibitor How the FDA classifies it
What it treatsOsilodrostat, sold as Isturisa tablets, treats endogenous hypercortisolemia (too much cortisol made by your own body) in adults with Cushing's syndrome. It is used when surgery is not an option or has not been curative.
- How you get it Prescription only
- Comes asTablet (by mouth)
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- What Medicaid pays
- $196.86 a tablet
- Isturisa tablets: Medicaid paid $231.33 to $1,042.11 a tablet
- Generic launchOctober 2035 Our estimate for the first generic of Isturisa
The Pharmacist’s Take
Osilodrostat (Isturisa) is a specialist medicine for adults with Cushing's syndrome when surgery is not an option or has not cured it, lowering cortisol by blocking the adrenal enzyme that finishes making it; it has been on the U.S. market since about 2020 and is not available as a generic. Tiredness, nausea, headache and swelling are what people notice most, and the first three can blur with signs of cortisol dropping too low. The one thing to watch for is that drop, which can come at any point and turn into life-threatening adrenal insufficiency, so call your doctor right away for vomiting, belly pain or dizziness.
Key Takeaways From the HelloPharmacist Team
- Take it by mouth twice a day, with or without food, and if you miss a dose, just take the next one at the usual time.
- Expect regular cortisol tests, plus an ECG (heart tracing) and potassium and magnesium checks, with the dose raised slowly based on results.
- Report new swelling, muscle cramps, rising blood pressure, acne or extra hair growth, which can signal low potassium or hormone buildup.
- Before starting clarithromycin, itraconazole, rifampin or carbamazepine, check with your pharmacist, since they can raise or lower osilodrostat levels.
Patient Information Guide for Osilodrostat
What It’s Used For
Osilodrostat is used for one condition.
- Isturisa tablets (by mouth) treat endogenous hypercortisolemia in adults with Cushing's syndrome when surgery is not an option or has not been curative.
How It Works
Osilodrostat is a cortisol synthesis inhibitor. It blocks 11beta-hydroxylase (CYP11B1), the adrenal enzyme that performs the final step in making cortisol. With that step blocked, the body makes less cortisol.
Drug Class
Drug Class
- Cortisol Synthesis Inhibitor
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Cortisol Synthesis Inhibitor
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Cytochrome P450 2D6 Inhibitors
- Cytochrome P450 1A2 Inhibitors
- Cytochrome P450 2C19 Inhibitors
- Cytochrome P450 3A4 Inhibitors
- Cytochrome P450 3A5 Inhibitors
- Cytochrome P450 11B1 Inhibitors
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Osilodrostat in the FDA’s index.
From our Patient Information GuideOsilodrostat is a cortisol synthesis inhibitor. It blocks 11beta-hydroxylase (CYP11B1), the adrenal enzyme that performs the final step in making cortisol. With that step blocked, the body makes less cortisol. Read How Osilodrostat Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)None listed for Osilodrostat in the FDA’s index.
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Anticorticosteroids
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Isturisa is taken by mouth twice a day, with or without food. Your prescriber starts with a low dose and adjusts it gradually, no more often than every 2 weeks at first.
The adjustments depend on cortisol tests, tolerability and symptoms.
- Cortisol is checked often until your response is steady, then every 1 to 2 months or as needed.
- If you miss a dose, take the next one at the regular time.
- Follow your prescriber and the label for your exact dose.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
High cortisol levels from Cushing's syndrome
Adults · Starting dose Starting dose 2 mg twice a day
- 2 mg orally twice daily, with or without food
Adults · Titration and maintenance dose Highest dose 30 mg twice a day
Step by step
- Titrate by 1 mg to 2 mg twice daily, no more frequently than every 2 weeks based on cortisol changes, tolerability and symptoms; if 10 mg twice daily is tolerated and 24-hour urine free cortisol stays above the upper normal limit, titrate further by 5 mg twice daily every 2 weeks
- Maintenance dosage varied between 2 mg and 7 mg twice daily in clinical trials
Adults with moderate liver problems (Child-Pugh B) · Starting dose Starting dose 1 mg twice a day
Good to know
More frequent monitoring of adrenal function may be required during titration
Adults with severe liver problems (Child-Pugh C) · Starting dose Starting dose 1 mg once a day in the evening
Good to know
More frequent monitoring of adrenal function may be required during titration
Side Effects
Common side effects include:
Common side effects
- Adrenal insufficiency (low cortisol effects)
- Tiredness
- Nausea
- Headache
- Swelling (edema)
- Decreased appetite
- Joint pain
- Muscle pain
- Nausea, vomiting and diarrhea
When to get medical help
- Call your doctor right away if you have nausea, vomiting, unusual tiredness, belly pain, loss of appetite or dizziness. These can signal low cortisol, which can become life-threatening.
- Get help if you faint or have a racing or irregular heartbeat, since the drug can affect heart rhythm (QT prolongation).
- Tell your doctor about muscle weakness or cramps, new or worsening high blood pressure, or swelling. These can come from low potassium or hormone buildup.
- Tell your doctor if you notice extra hair growth or acne (in women), which can come from higher androgen (male hormone) levels.
Warnings and Precautions
- Hypocortisolism: Cortisol can fall too low and cause life-threatening adrenal insufficiency. Symptoms include nausea, vomiting, tiredness, belly pain, dizziness and low blood pressure. Low cortisol can persist after stopping.
- QT prolongation: It can affect heart rhythm. An ECG is needed before and after starting. Take extra care if you have heart failure, a slow heartbeat, long QT syndrome or low electrolytes.
- Hormone buildup: It can cause low potassium, higher blood pressure, swelling, and extra hair growth or acne in women.
Interactions
Some medicines change how much osilodrostat is in your body.
- Strong CYP3A4 inhibitors (itraconazole, clarithromycin): raise levels, so the dose is halved.
- Strong CYP3A4/CYP2B6 inducers (carbamazepine, rifampin, phenobarbital): lower levels and may reduce effect.
- Stopping those inducers: can raise levels and side effects.
- Theophylline, tizanidine and similar drugs: osilodrostat can raise their levels, so use caution.
Interactions Listed in the FDA-Approved Label
From the Osilodrostat prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Strong CYP3A4 inhibitors For example: itraconazole, clarithromycinWhat happensMay increase osilodrostat concentration and the risk of ISTURISA-related adverse reactions.What to doReduce the dose of ISTURISA by half.
-
Strong CYP3A4 and CYP2B6 inducers For example: carbamazepine, rifampin, phenobarbitalWhat happensMay decrease osilodrostat concentration and reduce efficacy; stopping the inducer may increase concentration and the risk of adverse reactions.What to doMonitor cortisol concentration and signs and symptoms; an increase in ISTURISA dosage may be needed during use, and a reduction may be needed after the inducer is stopped.
-
CYP1A2 and CYP2C19 substrates with a narrow therapeutic index For example: theophylline, tizanidine, S-mephenytoinWhat happensISTURISA may affect these drugs when coadministered.What to doUse with caution.
Read the label’s full interactions text
7 DRUG INTERACTIONS CYP3A4 Inhibitor: Reduce the dose of ISTURISA by half with concomitant use of a strong CYP3A4 inhibitor CYP3A4 and CYP2B6 Inducers: An increase of ISTURISA dosage may be needed if ISTURISA is used concomitantly with strong CYP3A4 and CYP2B6 inducers. A reduction in ISTURISA dosage may be needed if strong CYP3A4 and CYP2B6 inducers are discontinued while using ISTURISA 7.1 Effect of Other Drugs on ISTURISA The effect of other drugs on ISTURISA can be found in Table 3. Table 3: Effect of Other Drugs on ISTURISA CYP3A4 Inhibitors Clinical Impact: Concomitant use of ISTURISA with a strong CYP3A4 inhibitor (e.g., itraconazole, clarithromycin) may cause an increase in osilodrostat concentration and may increase the risk of ISTURISA-related adverse reactions. Intervention: Reduce the dose of ISTURISA by half with concomitant use of a strong CYP3A4 inhibitor. CYP3A4 and CYP2B6 Inducers Clinical Impact: Concomitant use of ISTURISA with strong CYP3A4 and/or CYP2B6 inducers (e.g., carbamazepine, rifampin, phenobarbital) may cause a decrease in osilodrostat concentration and may reduce the efficacy of ISTURISA. Discontinuation of strong CYP3A4 and/or CYP2B6 inducers while using ISTURISA may cause an increase in osilodrostat concentration and may increase the risk of ISTURISA-related adverse reactions. Intervention: During concomitant use of ISTURISA with strong CYP3A4 and CYP2B6 inducers, monitor cortisol concentration and patient's signs and symptoms. An increase in ISTURISA dosage may be needed. Upon discontinuation of strong CYP3A4 and CYP2B6 inducers during ISTURISA treatment, monitor cortisol concentration and patient's signs and symptoms. A reduction in ISTURISA dosage may be needed.
Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Low potassium or magnesium must be corrected first, and a baseline ECG is needed.
- Tell your doctor about heart rhythm problems or heart failure.
- Moderate or severe liver impairment means a lower starting dose.
- Kidney impairment needs no dose change.
- Pregnancy: no human data are available.
- Breastfeeding is not recommended during treatment and for at least one week afterward.
- Not established for children.
- No dose change is needed for older adults.
Overdose
Too much can cause severe hypocortisolism, with nausea, vomiting, tiredness, low blood pressure, belly pain, dizziness or fainting. If an overdose is suspected, Isturisa is paused, cortisol is checked, and steroid replacement is given if needed. Close monitoring of QT interval, blood pressure, glucose, fluids and electrolytes may be necessary.
Half-Life and How Your Body Processes It
It is absorbed quickly, peaking in about 1 hour. Food slightly slows absorption but does not matter clinically. Its half-life is about 4 hours. It is cleared mostly by metabolism through several enzymes, and metabolites leave mainly in the urine. Moderate or severe liver impairment raises exposure.
Storage
Store at room temperature between 20°C to 25°C (68°F to 77°F); excursions permitted 15°C to 30°C (59°F to 86°F); protect from moisture.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Osilodrostat: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Osilodrostat — the kind of thing our pharmacy team would talk through with you at the counter.
What is osilodrostat (Isturisa) used for?
What happens if I miss a dose of osilodrostat?
Can I take osilodrostat with food?
What side effects should I call my doctor about?
Do I need tests while taking osilodrostat?
Can I take osilodrostat if I'm pregnant or breastfeeding?
Is osilodrostat available over the counter?
When was osilodrostat first available?
What is the brand name of osilodrostat?
What is the generic name of Isturisa?
What drug class is osilodrostat?
What strengths does osilodrostat come in?
How much does osilodrostat cost?
Is there a osilodrostat shortage?
Where can I read the osilodrostat prescribing information (package insert)?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Osilodrostat
Skip the scrolling. Ask in your own words and get an answer from Osilodrostat’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Osilodrostat’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Osilodrostat on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Osilodrostat Forms and Strengths (How It Comes)
Osilodrostat comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Osilodrostat inactive ingredients by manufacturer.
Tablet
How this form is used
- Isturisa is used for endogenous hypercortisolemia in adults with Cushing's syndrome when surgery is not an option or has not been curative.
- Isturisa is taken by mouth twice daily, with or without food.
- Isturisa dosing is raised gradually based on cortisol levels and symptoms.
- If you miss a dose of Isturisa, take the next dose at the regular time.
Osilodrostat on the U.S. Market: Products, Makers and Brands
How Osilodrostat appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
1 company lists 4 Osilodrostat product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 2020. The one brand name in the directory today is Isturisa; the rest are generics.
Also listed with the FDA, not a patient dose form: Unfinished tablet, film coated (3) · Powder (2) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
How Widely Osilodrostat Is Used (Medicaid Data)
How many Osilodrostat prescriptions Medicaid paid for in Q2 2025 – Q1 2026, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Osilodrostat prescribed? Of the 1,682 medications we measure, Osilodrostat ranks #1,329 by Medicaid prescriptions — more than 21% of them.
Utilization by Osilodrostat product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
osilodrostat 1 MG Oral Tablet Most dispensed
2 of 5 listed NDCs had Medicaid claims. RxNorm 2286275
osilodrostat 5 MG Oral Tablet
1 of 5 listed NDCs had Medicaid claims. RxNorm 2286288
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 3 of the 10 listed Osilodrostat NDCs had Medicaid claims.
Compare Osilodrostat Products
A representative set of FDA-listed product records for Osilodrostat — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| 1 mg | Oral | Recordati Rare Diseases, Inc. × 2 listings | NDA | View NDC → |
| 5 mg | Oral | Recordati Rare Diseases, Inc. × 2 listings | NDA | View NDC → |
Showing 4 of 4 products — FDA National Drug Code Directory. See every product, package size and price: browse all 4 Osilodrostat NDCs →
Osilodrostat Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Osilodrostat — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Osilodrostat in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Osilodrostat FDA Approval History
How Osilodrostat went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Osilodrostat Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Osilodrostat recalls since July 2021.
✅No Osilodrostat recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Osilodrostat in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 1
- Strengths
- 3
- Forms in current FDA listings
- 1 of 1
RxCUI 2286252 RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Osilodrostat Supply and Shortage Status
Whether Osilodrostat is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Medicaid Pays for Osilodrostat
CMS’s weekly pharmacy survey (NADAC) has no price for Osilodrostat, so here is what state Medicaid programs paid for it over the four quarters through Q1 2026, before rebates. It is not your price at the counter.
| Form | Strength | Version | What Medicaid paid | |
|---|---|---|---|---|
| Tablet · Oral | 1 mg | — | $196.86 per tablet | NDC details & Medicaid use |
| Tablet · Oral | 1 mg | Isturisa (brand) | $231.33 per tablet | NDC details & Medicaid use |
| Tablet · Oral | 5 mg | Isturisa (brand) | $1,042.11 per tablet | NDC details & Medicaid use |
Source: CMS State Drug Utilization Data, total paid divided by units paid for across every state, for each strength’s packages.
Osilodrostat Brand Names
Osilodrostat has one brand name on record: Isturisa. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Osilodrostat: Manufacturers and Labelers
One company lists Osilodrostat products with the FDA. By number of product records, the largest are Recordati Rare Diseases, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Osilodrostat Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Recordati Rare Diseases, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →